medline.ch Onkologie Urologische Tumoren

	Efficacy and Safety of Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Non-BRCA Mutation Subgroup of Patients with Metastatic Castration-resistant Prostate Cancer in the PROpel Trial. Eur Urol Oncol Mehra N, Clarke NW, Armstrong AJ, Oya M, Shore N, Procopio G, Guedes JD, Arslan C, Brown E, Joung JY, Sugimoto M, Choi YD, Castellano D, Ürün Y, Hosius C, McGuinness D, Degboe A, Saad F. PMID: 42833926 [PubMed - as supplied by publisher]
	Two-stage high-frequency ultrasonic characterization of ex vivo renal tumor microstructure. Ultrasound Med Biol Zuluaga L, Gleed AD, Bamby J, Okhawere KE, Levieddin J, Ucpinar B, Ucpinar BA, Hoerig C, Mamou J, Badani KK. PMID: 42833906 [PubMed - as supplied by publisher]
	Testosterone breakthrough and outcomes during intensified therapy in metastatic hormone-sensitive prostate cancer: the ARASENS and LATITUDE trials. BJU Int Xiao X, Ni X, Zhao Y, Li X, Wang S, Wang H, Ye D, Wu J, Zhu Y. PMID: 42833883 [PubMed - as supplied by publisher]
	Integrated computational framework for drug repurposing in metastatic prostate cancer using transcriptomic meta-analysis, machine learning, and molecular modeling. Comput Biol Chem Rafiee J, Arabi Baygi ST, Aghaee-Bakhtiari SH. PMID: 42833027 [PubMed - as supplied by publisher]
	Explainable Machine Learning-Based Prediction of Progression-Free Survival in Prostate Cancer: Retrospective Cohort Study. JMIR Cancer Tun HM, Naing L, Malik OA, Abdullah MS, Ta T, Rahman HA. PMID: 42832781 [PubMed - indexed for MEDLINE]
	Leveraging Artificial Intelligence to Monitor Patients With Prostate Cancer in a Retrospective Cohort of Radiation Oncology Clinic Patients. Clin J Oncol Nurs Boyajian RN, Hagen M, Bagchi S, Mahatma S, Kowtoniuk A, Trinh QD, Kumar T, Nguyen PL. PMID: 42832322 [PubMed - indexed for MEDLINE]
	Full-Field Optical Coherence Tomography for Immediate Analysis of Prostate Biopsy Cores: A New Step toward Real-Time Cancer Diagnosis. Ann Surg Oncol Anract J, Chen W, Duquesne I, Larnaudie L, Diamand R, Sibony M, Barry Delongchamps N. PMID: 42832144 [PubMed - as supplied by publisher]
	Targeted pelvic lymph node dissection using magnetic resonance imaging - ultrasonography fusion technique and indocyanine green injection in robot-assisted radical prostatectomy. J Robot Surg Yamada Y, Kimura N, Hakozaki Y, Nakamura M, Sugano K, Sugimoto K, Kakutani S, Miyakawa J, Kamei J, Niimi A, Taguchi S, Kume H. PMID: 42832079 [PubMed - indexed for MEDLINE]
	The effect of ureteral stenting on the risk of metachronous upper tract urothelial carcinoma in patients with bladder tumors involving the ureteral orifice. World J Urol Pyrgidis N, Engelmann P, Puhr-Westerheide D, Ebner B, Kidess M, Semmler M, Keller P, Stief C, Schulz GB, Volz Y. PMID: 42832054 [PubMed - indexed for MEDLINE]
	Partial vs. whole-gland salvage hifu after radiotherapy failure: oncological and functional outcomes. World J Urol Maillard C, Mebroukine S, Haaser T, Pasticier G, Robert G, Bladou F. PMID: 42831949 [PubMed - indexed for MEDLINE]
	A Clinical Insight into Von Hippel-Lindau Syndrome: Diagnostic Challenges. Prague Med Rep Rosado GAC, da Cunha AC, Duarte ML, de Abreu VMG. PMID: 42831607 [PubMed - indexed for MEDLINE]
	PRECISE Assessment of Sequential Biparametric MRI and Clinically Significant Prostate Cancer in Biopsy-naive Men: A Retrospective Cohort Study. Eur Urol Open Sci Tian Y, Liu Z, Chen S, Zhou Y, Ruan M, Li D, Wu J, Fan Y, Liu Y. PMID: 42831142 [PubMed]
	Incidence, Patterns, and Predictive Factors of Biochemical Failure Following Definitive Radiotherapy for Localized Prostate Cancer: A Retrospective Military Cohort Study. Cureus Alnajada W, Ghnmein NM, Ayyad R, Abukaff A, Bani Essa M, Alhabahbeh L, Daheerat AN, Alzyoud A, Alhiary Z. PMID: 42829772 [PubMed]
	Recent Advances in Cyclic Peptide-Based Therapeutic Strategies for Renal Cell Carcinoma: A Focused Review. Drug Des Devel Ther Sun L, Li X, Liu Y, Wu G. PMID: 42829760 [PubMed - indexed for MEDLINE]
	Exploring regulated cell death in renal cell carcinoma: mechanistic insights and therapeutic perspectives. Apoptosis Zhu G, Zhang H, Li Y, Ma W, Yao Y, Lyu D, Lu B, Zong Y, Dong K, Zhou W, Liu Y, Cui X, Pan X. PMID: 42829358 [PubMed - indexed for MEDLINE]
	Re: Sobia Khan, Nathan Papa, Andrew Kneebone, et al. Prospective Comparison of (64)Copper [(64)Cu]SAR-bisPSMA vs (68)Gallium [(68)Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial). Eur Urol 2026;89:512-20. Eur Urol Hindié E, Callaud A, Morgat C. PMID: 42829270 [PubMed - as supplied by publisher]
	Reply to Paolo Zaurito's Letter to the Editor re: Robert M. Meier, Nima Aghdam, Alan C. Beckman, et al. 10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.029. Eur Urol Meier R, Aghdam N, Kaplan I. PMID: 42829268 [PubMed - as supplied by publisher]
	Reply to Riccardo Lombardo's Letter to the Editor re: Bi-Ming He, Keqin Zhang, Zhien Zhou, et al. Cognitive Versus Software-based Fusion targeted Biopsy for the Diagnosis of Clinically Significant Prostate Cancer: A Multicenter, Randomized, Noninferiority Trial (IMAGINATION). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.06.020. Eur Urol He BM, Wang HF. PMID: 42829267 [PubMed - as supplied by publisher]
	PSMA-PET/CT-guided Intensification of Radiation Therapy for Prostate Cancer (PSMAgRT): 5-yr Analysis of a Phase 2 Randomized Controlled Trial. Eur Urol Belliveau C, Saad F, Duplan D, Petit C, Delouya G, Lambert C, Taussky D, Barkati M, Beauchemin MC, Clavel S, Mok G, Gauthier-Paré AS, Igidbashian L, Jolicoeur M, Nguyen TV, McLaughlin PY, Wong P, Keu KV, DaSilva JN, Juneau D, Ménard C. PMID: 42829266 [PubMed - as supplied by publisher]
	Re: Microultrasonography-guided Versus MRI-guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial. Eur Urol Girometti R, Giganti F. PMID: 42829264 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 181945

Seite 1 von 9098

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung